Personalized Medicine in Infectious Diseases
Leif Erik Sander and Christian Gaebler
The goal of our "Personalized Medicine in Infectious Diseases" research group is to develop innovative preventive and therapeutic strategies against infectious diseases and their consequences. Infectious diseases are not only among the leading causes of death worldwide, but they are also directly and indirectly linked to non-communicable diseases such as cardiovascular and malignant diseases. Additionally, a causal relationship between infections and inflammatory diseases such as multiple sclerosis (EBV) is well established. Therefore, the prevention and effective treatment of infectious diseases are of the highest global priority.
Our research group utilizes cutting-edge technologies to analyze antimicrobial immune responses and develop new, highly effective anti-infective therapies and vaccines. This includes advanced methods of molecular genetic virus diagnostics, the development of modern, fully or partially synthetic modular vaccines, and the investigation and isolation of human monoclonal antibodies for innovative anti-infective strategies, such as antibody-drug conjugates.
Innovation and clinical translation with direct patient benefits are at the core of our mission. Public engagement and community involvement are crucial for successful innovation and progress towards effective prevention and treatment of infectious diseases, and these principles are firmly embedded in our work program.
| Name | Position |
|---|---|
| Prof. Leif Erik Sander | PI |
| Prof. Christian Gaebler | PI |
| Stefanie Jentzsch, M. Sc. | Lab Manager |
| Dr. Michela Perotti, PhD | Senior Scientist |
| Anna Hiller, MD | Physician |
| Victor Sikora, M.Sc. | PhD Student, Bioinformatics |
| Naomi Perkins, M.Sc. | PhD Student |
| Sabine Weickmann | Technical Assistant |